דוחות כספיים מלאים לרבעון השני 2025
false
טבע תעשיות פרמצבטיות בע"מ
2
380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no:
520013954
13365
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
30/07/2025
www.isa.gov.il
www.tase.co.il
Reference:
2025-02-056913
Time of broadcast:
23:08
23:08
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
דוחות כספיים מלאים לרבעון השני 2025
Q2_2025__Form_10Q__final__Banerless_isa.pdf
For an accessible version of this Quarterly Report on Form 10-Q, please visit www.tevapharm.com
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NYSE
Date of revision of form structure:
06/08/2024
Address:
Dvora Hanevi'a
124
,
Tel Aviv
6944020
,
Tel:
03-9148262
,
Fax:
03-9267519
E-mail address:
Yael.Ashman@teva.co.il
Previous names of reporting entity:
Name of the Signatory:
Kalif Eli
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Address:
Dvira Hanevia
124
,
Tel Aviv
6944020
Telephone:
03-9148262
Facsimile:
E-mail:
yael.ashman@teva.co.il
1